MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Award Announcements & Progress Reports: Federal Contracts, Grants & Cooperative Agreements
2022: On Jan. 13, 2021, the Department of Defense (DoD), in coordination with the U.S. Department of Health and Human Services (HHS), awarded contracts to Abbott Rapid Dx North America, LLC, iHealth Lab Inc., and Roche Diagnostics Corporation to purchase total of 380 million over-the-counter COVID-19 test kits.
F. Hoffmann-La Roche Holding Ltd (RHHBF; RHHBY)
Finance & Acquisitions: Roche
Parents
F. Hoffmann-La Roche Holding Ltd (RHHBF; RHHBY)
Children
2007: Roche acquires 454 Life Sciences to strengthen presence in ultra-fast gene sequencing (2007)
2011: Anadys Pharmaceuticals Surprises the Street, Gets Acquired by Roche for $230M (2011)
2011: Curetis Attracts Financing From Roche for Series A (2011)
2011: Roche Acquires MTM Laboratories AG for Up to $260 Million (2011)
2011: Roche Holding AG To Buy Diagnostics Company PVT (2011)
2012: $13 million Series B, Domain Associates, Roche Venture Fund, Pfizer Venture Investments
2012: Roche aims to boost genetic testing offering with $5.7bn Illumina hostile takeover bid (2012)
2014: Roche Back in Sequencing Game with $350M Genia Acquisition
2014: Roche Snags Diagnostics Company IQuum In 450 Million
2014: Roche to acquire Santaris Pharma to expand discovery and development of RNA-targeting medicines
2015: Roche buys privately-held GeneWEAVE BioSciences
2016: Roche Acquires Tensha Therapeutics for $115M Upfront
2017: Roche buys diabetes app firm, mySugr, in digital health push - Reuters
2018: Roche pays $1.9B for Ex-Googlers’ tech startup Flatiron Health – Endpoints News
2019: Roche joins the M&A game, closing in on a deal to buy gene therapy pioneer Spark for $5B
2019: Roche nearing $5 billion deal to acquire Spark Therapeutics: WSJ
2019: Roche pays $2.4 billion for rest of cancer expert Foundation Medicine
2020: Atea Pharmaceuticals Announces Strategic Collaboration with Roche to Develop and Distribute AT-527 for Patients with COVID-19
2020: Roche inks $308.6M collaboration deal with Lead Pharma, focusing on immune-mediated disease
2021: Roche drops $1.85B for GenMark's testing tech as pandemic, antibiotic resistance threats loom
2021: Roche's gene therapy plans take Shape with $3B-plus biobucks deal
2022: Good Therapeutics Announces Acquisition of Conditionally Active PD-1-regulated IL-2 Program by Roche
2022: Roche Holdings AG Basel ADR Common Stock (RHHBY) Investor Presentation - Slideshow_ seekingalpha.com
2022: Strategic Alliance with Roche
2023: Roche to buy part of LumiraDx diagnostics platform for $295 million
2023: Updated: Roche buys obesity and diabetes biotech Carmot Therapeutics in $2.7B merger deal
2024: Roche enters into a definitive agreement to acquire Poseida Therapeutics, including cell therapy candidates and related platform technologies
2025: Roche continues ADC dealmaking spree with $1B biobucks pact with Oxford BioTherapeutics
2025: Roche Holding AG 2024 Q4 - Results - Earnings Call Presentation
2025: Roche, Manifold Bio to advance new brain shuttles in pact worth up to $2B+
2025: Strategic Acquisition of 89bio by Roche Highlights Promising Growth in MASH and FGF21 Market
454 Life Sciences
89bio, Inc. (Nasdaq: ETNB)
Anadys Pharmaceuticals, Inc
BioImagene
Carmot Therapeutics Inc. (CRMO)
CHUGAI PHARMACEUTICAL CO.,LTD
Flatiron Health
FOUNDATION MEDICINE, INC. (NASDAQ:FMI)
Genentech, Inc., (NYSE:DNA) #1 Largest Biotechnology Company
GeneWeave Biosciences
Genia Technologies
Genmark Diagnostics Inc. (NASDAQ: GNMK)
Good Therapeutics, Inc.
Inflazome
IQuum
Marcadia Biotech
Medingo Ltd
MTM Laboratories
mySugr
Poseida Therapeutics Inc. (NASDAQ PSTX)*
Promedior Pharmaceuticals
PVT
Roche Venture Fund
Saga Diagnostics
Santaris Pharma
Spark Therapeutics (NASDAQ:ONCE)
Telavant
Tensha Therapeutics
The Group posted sales of 49.1 billion Swiss francs.
Tusk Therapeutics
Ventana Medical Systems, Inc-VMSI
Jumps
*Key People: Roche
Organization & Developments: Roche